Sun Pharmaceutical Industries Limited announced that Mr. Ashok I Bhuta will cease to be the Compliance Officer of the Company with effect from close of business hours on May 31, 2022 as a result of completion of his tenure in the employment of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,521 INR | +0.30% | +3.65% | +20.76% |
12:42pm | India plans incentives for diabetes, obesity drug makers in 2026, government official says | RE |
25/06 | Sun Pharma Completes Taro Pharmaceutical Industries Merger | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.76% | 43.59B | |
+28.00% | 22.54B | |
+20.10% | 15.73B | |
+18.82% | 14.33B | |
+55.83% | 12.75B | |
-0.05% | 6.79B | |
-12.70% | 6.48B | |
-8.87% | 5.73B | |
+15.72% | 5.67B | |
+8.29% | 4.67B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Limited Announces Cessation of Mr. Ashok I Bhuta as Compliance Officer